A detailed history of Private Capital Group, LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Private Capital Group, LLC holds 151 shares of BHVN stock, worth $5,458. This represents 0.02% of its overall portfolio holdings.

Number of Shares
151
Previous 111 36.04%
Holding current value
$5,458
Previous $13,000 69.23%
% of portfolio
0.02%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

BUY
$83.14 - $145.99 $3,325 - $5,839
40 Added 36.04%
151 $22,000
Q1 2022

Apr 21, 2022

BUY
$110.08 - $142.92 $880 - $1,143
8 Added 7.77%
111 $13,000
Q4 2021

Jan 24, 2022

BUY
$99.73 - $148.48 $10,272 - $15,293
103 New
103 $14,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.59B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.